These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 239225)

  • 41. Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions.
    Miyamoto MD
    J Physiol; 1975 Aug; 250(1):121-42. PubMed ID: 240928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ryanodine facilitates calcium-dependent release of transmitter at mouse neuromuscular junctions.
    Nishimura M; Tsubaki K; Yagasaki O; Ito K
    Br J Pharmacol; 1990 May; 100(1):114-8. PubMed ID: 1973623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of ATP-sensitive K(+)-channel activators on transmitter release parameters at the frog neuromuscular junction.
    Salgado D; Shek EW; Alkadhi KA
    Brain Res; 1993 Apr; 609(1-2):307-12. PubMed ID: 8099524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of calcium channel blockers on stimulation-induced changes in transmitter release at the frog neuromuscular junction.
    Zengel JE; Lee DT; Sosa MA; Mosier DR
    Synapse; 1993 Dec; 15(4):251-62. PubMed ID: 7908759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of physiologic alterations on binomial transmitter release at magnesium-depressed neuromuscular junctions.
    Branisteanu DD; Miyamoto MD; Volle RL
    J Physiol; 1976 Jan; 254(1):19-37. PubMed ID: 175150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transmitter release at the mouse neuromuscular junction stimulated by cadmium ions.
    Nishimura M; Tsutsui I; Yagasaki O; Yanagiya I
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):106-21. PubMed ID: 6149733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Noradrenaline augments tetanic potentiation of transmitter release by a calcium dependent process.
    Bergman H; Glusman S; Harris-Warrick RM; Kravitz EA; Nussinovitch I; Rahamimoff R
    Brain Res; 1981 Jun; 214(1):200-4. PubMed ID: 6263418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maitotoxin activates quantal transmitter release at the neuromuscular junction: evidence for elevated intraterminal Ca2+ in the motor nerve terminal.
    Kim YI; Login IS; Yasumoto T
    Brain Res; 1985 Nov; 346(2):357-62. PubMed ID: 2996708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein phosphatase inhibitor okadaic acid enhances transmitter release at neuromuscular junctions.
    Abdul-Ghani M; Kravitz EA; Meiri H; Rahamimoff R
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1803-7. PubMed ID: 1672044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of hydrostatic pressure on the spontaneous release of transmitter at the frog neuromuscular junction.
    Ashford ML; MacDonald AG; Wann KT
    J Physiol; 1982 Dec; 333():531-43. PubMed ID: 6133947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Barbiturates and transmitter release at the frog neuromuscular junction.
    Pincus JH; Insler NF
    Brain Res; 1981 May; 213(1):127-37. PubMed ID: 6113031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of cholinergic compounds on spontaneous quantal mediator release at the neuromuscular synapse of the frog].
    Bukharaeva EA; Nikol'skiĭ EE; Giniatullin RA
    Neirofiziologiia; 1986; 18(5):586-93. PubMed ID: 2877404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of phorbol ester on spontaneous transmitter release at frog neuromuscular junction.
    Eusebi F; Molinaro M; Caratsch CG
    Pflugers Arch; 1986 Feb; 406(2):181-3. PubMed ID: 2870468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Facilitation and impulse propagation failure at the frog neuromuscular junction.
    Barton SB; Cohen IS
    Pflugers Arch; 1982 Feb; 392(4):327-34. PubMed ID: 6280127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the ionophore X-537A on acetylcholine release at the frog neuromuscular junction.
    Kita H; Van Der Kloot W
    J Physiol; 1976 Jul; 259(1):177-98. PubMed ID: 182959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Mg2+ on the stimulation-induced changes in transmitter release at the frog neuromuscular junction.
    Tanabe N; Morota A; Kijima H
    Zoolog Sci; 1995 Jun; 12(3):265-70. PubMed ID: 7580810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depression by calcium of spontaneous transmitter release at the mammalian neuromuscular junction.
    Kim YI; Sanders DB
    Brain Res; 1979 Jun; 169(1):111-9. PubMed ID: 36963
    [No Abstract]   [Full Text] [Related]  

  • 58. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction.
    Barrett EF; Barrett JN; Botz D; Chang DB; Mahaffey D
    J Physiol; 1978 Jun; 279():253-73. PubMed ID: 209175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of protein kinase C increases acetylcholine release from frog motor nerves by a direct action on L-type Ca(2+) channels and apparently not by depolarisation of the terminal.
    Arenson MS; Evans SC
    Neuroscience; 2001; 104(4):1157-64. PubMed ID: 11457598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. At the frog neuromuscular junction prostaglandin synthase inhibitors depress and PGE partially restores quantal acetylcholine release.
    Madden KS; van der Kloot W
    Brain Res; 1982 Feb; 234(2):464-8. PubMed ID: 6277436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.